{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:59:16Z","timestamp":1766087956830},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,16]]},"DOI":"10.7759\/cureus.31579","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T19:31:19Z","timestamp":1668627079000},"source":"Crossref","is-referenced-by-count":3,"title":["A Case Report of Mesothelioma Response to Endocrine Therapy in Synchronous Breast Cancer and Pleural Epithelioid Mesothelioma: A Double Exemestane Effect"],"prefix":"10.7759","author":[{"given":"Marta","family":"Pina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rute","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-69","article-title":"Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease","volume":"13","author":"Nuvoli B","year":"2014","unstructured":"Nuvoli B, Germoni S, Morosetti C, et al.. Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease. Mol Cancer. 2014, 13:69. 10.1186\/1476-4598-13-69","journal-title":"Mol Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.11.11","article-title":"Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted\/banned asbestos use","volume":"9","author":"Alpert N","year":"2020","unstructured":"Alpert N, van Gerwen M, Taioli E. Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted\/banned asbestos use. Transl Lung Cancer Res. 2020, 9:S28-38. 10.21037\/tlcr.2019.11.11","journal-title":"Transl Lung Cancer Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"33","author":"Popat S","year":"2022","unstructured":"Popat S, Baas P, Faivre-Finn C, et al.. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2022, 33:129-42. 10.1016\/j.annonc.2021.11.005","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000256102.40842.78","article-title":"An association between postoperative radiotherapy for primary breast cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) studies and the subsequent appearance of pleural mesothelioma","volume":"30","author":"Deutsch M","year":"2007","unstructured":"Deutsch M, Land SR, Begovic M, Cecchini R, Wolmark N. An association between postoperative radiotherapy for primary breast cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) studies and the subsequent appearance of pleural mesothelioma. Am J Clin Oncol. 2007, 30:294-6. 10.1097\/01.coc.0000256102.40842.78","journal-title":"Am J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01685.x","article-title":"Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals","volume":"43","author":"Attanoos RL","year":"2003","unstructured":"Attanoos RL, Thomas DH, Gibbs AR. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals. Histopathology. 2003, 43:387-92. 10.1046\/j.1365-2559.2003.01685.x","journal-title":"Histopathology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.14202","article-title":"Synchronous breast carcinoma and peritoneal mesothelioma","volume":"27","author":"Prathibha S","year":"2021","unstructured":"Prathibha S, Beckwith H, Kratzke RA, Klein M, Kne A, Tuttle TM. Synchronous breast carcinoma and peritoneal mesothelioma. Breast J. 2021, 27:550-2. 10.1111\/tbj.14202","journal-title":"Breast J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950801)76:3<437::aid-cncr2820760314>3.0.co;2-a","article-title":"Malignant pleural mesothelioma after radiation therapy for breast cancer. A report of two additional patients","volume":"76","author":"Shannon VR","year":"1995","unstructured":"Shannon VR, Nesbitt JC, Libshitz HI. Malignant pleural mesothelioma after radiation therapy for breast cancer. A report of two additional patients. Cancer. 1995, 76:437-41. 10.1002\/1097-0142(19950801)76:3&lt;437::aid-cncr2820760314&gt;3.0.co;2-a","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2010.42.4.217","article-title":"Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites","volume":"42","author":"Kim JH","year":"2010","unstructured":"Kim JH, Rha SY, Kim C, et al.. Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites. Cancer Res Treat. 2010, 42:217-24. 10.4143\/crt.2010.42.4.217","journal-title":"Cancer Res Treat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/028418602760169361","article-title":"Therapy-associated solid tumors","volume":"41","author":"Travis LB","year":"2002","unstructured":"Travis LB. Therapy-associated solid tumors. Acta Oncol. 2002, 41:323-33. 10.1080\/028418602760169361","journal-title":"Acta Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-015-0624-4","article-title":"Effects of sex hormones on survival of peritoneal mesothelioma","volume":"13","author":"Huang Y","year":"2015","unstructured":"Huang Y, Alzahrani NA, Liauw W, Morris DL. Effects of sex hormones on survival of peritoneal mesothelioma. World J Surg Oncol. 2015, 13:210. 10.1186\/s12957-015-0624-4","journal-title":"World J Surg Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31820cdd6f","article-title":"Aromatase inhibitor exemestane has antiproliferative effects on human mesothelioma cells","volume":"6","author":"Stoppoloni D","year":"2011","unstructured":"Stoppoloni D, Salvatori L, Biroccio A, et al.. Aromatase inhibitor exemestane has antiproliferative effects on human mesothelioma cells. J Thorac Oncol. 2011, 6:583-91. 10.1097\/JTO.0b013e31820cdd6f","journal-title":"J Thorac Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9964","article-title":"Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models","volume":"7","author":"Nuvoli B","year":"2016","unstructured":"Nuvoli B, Sacconi A, Cortese G, Germoni S, Murer B, Galati R. Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models. Oncotarget. 2016, 7:47116-26. 10.18632\/oncotarget.9964","journal-title":"Oncotarget"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02050-1","article-title":"Identification of novel COX-2\/CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities","volume":"40","author":"Nuvoli B","year":"2021","unstructured":"Nuvoli B, Antoniani B, Libener R, Maconi A, Sacconi A, Carosi M, Galati R. Identification of novel COX-2\/CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities. J Exp Clin Cancer Res. 2021, 40:257. 10.1186\/s13046-021-02050-1","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/117699-a-case-report-of-mesothelioma-response-to-endocrine-therapy-in-synchronous-breast-cancer-and-pleural-epithelioid-mesothelioma-a-double-exemestane-effect","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:00Z","timestamp":1707508200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/117699-a-case-report-of-mesothelioma-response-to-endocrine-therapy-in-synchronous-breast-cancer-and-pleural-epithelioid-mesothelioma-a-double-exemestane-effect"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.31579","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,16]]}}}